Novozymes A S DKK 2.0
13F holders, Q4 2024 (December 31)3holders −2
0new positions
2sold out
$56.47avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, down 2 from Q3 2024. 0 opened new positions and 2 sold out. The largest holders were Somerville Kurt F ($1.2M), Hemenway Trust Co LLC ($248K) and Kidder Stephen W ($222K).
- Company
- Novozymes A S DKK 2.0
- CUSIP
- B798FW902
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $532K |
All 13F filers, Q3 2024 → Q4 2024: 8,134 shares sold, net −8,134 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Somerville Kurt F | 0.20% | Reduce -0.5% | 21,290 | $1.2M |
| Hemenway Trust Co LLC | 0.02% | Reduce -10.7% | 4,396 | $248K |
| Kidder Stephen W | 0.07% | Reduce -2.5% | 3,925 | $222K |
"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.